-
Recent studies on heart failure treatment showed that SGLT2 inhibitors reduced the risk of cardiovascular death or even hospitalization in heart failure, with reduced ejection fraction compared to placebo.
-
The cardiovascular risk in diabetes is determined by some comorbidities. Renal dysfunction and micro- and macrovascular events are common. Should diabetes patients be screened for cardiovascular risks?
-
A research team developed an innovative antibody for chronic anemia treatment in dialysis patients. It allows for a lower EPO dose and the resulting minimization of cardiovascular risk.
-
According to a recent study, the movements and breathing during yoga have a positive influence on the symptoms in patients with atrial fibrillation.
-
Just send a selfie to the cardiologist and receive a heart disease risk assessment. Sounds futuristic? It could actually become routine, according to a recent study.
-
Dr. Vikramjeet Singh is investigating how the interaction of intestinal bacteria and immune cells influences a brain infarction, with a particular focus on microbial diversity in the intestine, and neutrophils.
-
Hepatitis-C eradication by 2030, as required by the WHO, is within reach in Spain. Dr. Joaquin Cabezas explains how the country is making prisons HCV-free by near 100% diagnosis and 100% treatment.
-
NAFLD is a form of fatty liver (steatosis hepatitis) not caused by increased alcohol consumption. The prevalence in Europe is estimated to be between 20 and 30%.
-
Chronic liver disease is on the rise. Aside from undetected liver disease, abnormal liver function tests are often not followed up in primary care, or many patients ignore their follow-up appointments.
-
Hepatitis E represents a major health challenge worldwide and is still difficult to control. For example, prevention in disinfection is reaching its limits and vaccination is currently only available in China.
-
How does COVID-19 affect patients with liver disease? This was the topic of a special online session at the EASL digital congress 2020.
-
HIV coinfection is quite common in HCV patients. However, little research has been done on the influence of such co-infections on the morbidity and mortality of those affected.
-
With the help of the Europe-wide PREDICT study, an international research association determined three forms of acute decompensated liver cirrhosis.
-
Researchers identified a microRNA in obese female mice that transmit a potential risk of liver cancer to their offspring over generations.
-
Repeated measurement of the FIB-4 index score over several years helps to assess the risk of developing a serious liver disease such as cirrhosis, according to a recent study from Sweden.
-
The ATLS is a health care professionals training for treating traumatized patients in the early stages of hospitalization. Developed by the American College of Surgeons it originated in 1976.
-
The German Society for Urology (DGU) warns of a long-term increase in urological diseases as a result of climate change and its increasingly occurring extreme heatwaves.
-
A recent study has shown encouraging results for the use of hyperimmune plasma in COVID-19 patients, reducing mortality, improving respiratory function, and decreasing inflammatory indices.
-
The body's own regulation of a particular gene is associated with a reduced risk of developing post-traumatic stress disorder after a terrible experience.
-
A series of 22 autopsies showed that heart damage in COVID-19 deaths had a particular cell death pattern of individual cardiac myocytes and not the typical heart muscle inflammation associated with myocarditis.
